CSLLY (CSLLY) Stock Price & Analysis
CSLLY (CSLLY) fell 0.74% to USD 20 as of July 25, 2026 at 02:21 UTC, according to Nexqual real-time market data.
CSLLY last closed at USD 20.15; the session ranged USD 19.91–20.16 on volume of 34,321 shares. Market capitalization is $38.31B, with a 52-week range of USD 16.01–44.86 (OQX). Source: Nexqual, July 25, 2026 at 02:21 UTC.
Key Statistics (as of July 25, 2026 at 02:21 UTC)
| Price | USD 20 |
|---|---|
| Change | ▼ 0.74% (down) |
| Previous Close | USD 20.15 |
| Open | USD 19.91 |
| Day Range | USD 19.91 – 20.16 |
| 52-Week Range | USD 16.01 – 44.86 |
| Volume | 34,321 shares |
| Market Cap | $38.31B |
| Exchange | OQX |
Technical Analysis (CSLLY)
Nexqual's technical model rates CSLLY "NEUTRAL" based on 3 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 02:21 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 48.22 (neutral) |
| vs SMA50 | Above (USD 19.21) |
| MACD | 0.29 (positive) |
Analyst Ratings (CSLLY)
Wall Street analysts rate CSLLY "Hold" based on 1 analysts, with a mean price target of USD 24.1 (range USD 24.1–24.1), per Nexqual as of July 25, 2026 at 02:21 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 24.1 |
| High Target | USD 24.1 |
| Low Target | USD 24.1 |
| Buy / Hold / Sell | 0 / 1 / 0 |
Earnings (CSLLY)
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financials & Fundamentals (CSLLY)
| Total Revenue | $15.41B |
|---|---|
| Revenue Growth (YoY) | -1.80% |
| Gross Margin | +51.87% |
| Operating Margin | +31.65% |
| Profit Margin | +9.06% |
| ROE | +6.66% |
| Debt / Equity | 54.44 |
| Current Ratio | 2.57 |
| Total Cash | $1.14B |
| Total Debt | $11.14B |
| Free Cash Flow | $1.85B |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Financial Health Score (CSLLY)
Nexqual rates CSLLY's overall financial health "Solid" across five dimensions, as of July 25, 2026 at 02:21 UTC.
| Growth | Solid — Revenue +5% YoY (annual) |
|---|---|
| Profitability | Strong — Gross margin 52%, operating 32% |
| Balance Sheet | Strong — $1.14B cash vs $11.1B debt |
| Cash Flow | Solid — FCF $1.85B, 12% margin |
| Efficiency | Mixed — ROE 7%, ROA 6.6% |
Ownership (CSLLY)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +0.01% |
| Shares Outstanding | 1.92B |
| Float | 1.93B |
Source: Nexqual, July 25, 2026 at 02:21 UTC.
Leadership (CSLLY)
CSLLY is led by Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62), CEO, MD & Director, per Nexqual as of July 25, 2026 at 02:21 UTC.
| CEO, MD & Director | Gordon Naylor BEng (Hons), C.P.A., DipCompSc (age 62) |
|---|---|
| Chief Financial Officer | Ken Lim (age 51) |
| Executive VP & COO | Mary Oates (age 62) |
| Senior Vice President of Research & Development Strategic Operations | Deirdre BeVard |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CMXHF | CSL Ltd. | USD 81.96 | ▲ 0% |
| IDEXY | Industria de Diseno Textil Indi | USD 15.41 | ▼ 0.96% |
| MKKGY | Merck KGaA | USD 31.88 | ▲ 2.02% |
| CHGCY | Chugai Pharmaceutical Co., Ltd. | USD 22 | ▼ 1.57% |
| AAGIY | AIA Group, Ltd. | USD 39.94 | ▲ 1.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 02:21 UTC. This page is informational and not investment advice.